BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34804067)

  • 1. The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis.
    Fuentelsaz-Romero S; Barrio-Alonso C; García Campos R; Torres Torresano M; Muller IB; Triguero-Martínez A; Nuño L; Villalba A; García-Vicuña R; Jansen G; Miranda-Carús ME; González-Álvaro I; Puig-Kröger A
    Front Immunol; 2021; 12():776879. PubMed ID: 34804067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD14 Induces Pro-inflammatory Cytokines in Rheumatoid Arthritis Fibroblast-Like Synovial Cells via Toll-Like Receptor 4.
    Ichise Y; Saegusa J; Tanaka-Natsui S; Naka I; Hayashi S; Kuroda R; Morinobu A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32674360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
    Municio C; Dominguez-Soto Á; Fuentelsaz-Romero S; Lamana A; Montes N; Cuevas VD; Campos RG; Pablos JL; González-Álvaro I; Puig-Kröger A
    Ann Rheum Dis; 2018 May; 77(5):752-759. PubMed ID: 29431121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
    Front Immunol; 2018; 9():2228. PubMed ID: 30319663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis.
    Municio C; Soler Palacios B; Estrada-Capetillo L; Benguria A; Dopazo A; García-Lorenzo E; Fernández-Arroyo S; Joven J; Miranda-Carús ME; González-Álvaro I; Puig-Kröger A
    Ann Rheum Dis; 2016 Dec; 75(12):2157-2165. PubMed ID: 26920997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
    Cooper DL; Martin SG; Robinson JI; Mackie SL; Charles CJ; Nam J; ; Isaacs JD; Emery P; Morgan AW
    PLoS One; 2012; 7(1):e28918. PubMed ID: 22235253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.
    van der Heijden JW; Assaraf YG; Gerards AH; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
    Scand J Rheumatol; 2014; 43(1):9-16. PubMed ID: 23987246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis.
    Chara L; Sánchez-Atrio A; Pérez A; Cuende E; Albarrán F; Turrión A; Chevarria J; del Barco AA; Sánchez MA; Monserrat J; Prieto A; de la Hera A; Sanz I; Diaz D; Alvarez-Mon M
    J Transl Med; 2015 Jan; 13():2. PubMed ID: 25592233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYD88, IRAK3 and Rheumatoid Arthritis pathogenesis: Analysis of differential gene expression in CD14 + monocytes and the inflammatory cytokine levels.
    Gomes da Silva IIF; Barbosa AD; Souto FO; Maia MMD; Crovella S; Souza PRE; Sandrin-Garcia P
    Immunobiology; 2021 Nov; 226(6):152152. PubMed ID: 34735922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts.
    Yu S; Nakashima N; Xu BH; Matsuda T; Izumihara A; Sunahara N; Nakamura T; Tsukano M; Matsuyama T
    Rheumatol Int; 1998; 17(6):237-43. PubMed ID: 9592864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis.
    Singh A; Misra R; Aggarwal A
    Rheumatol Int; 2019 Aug; 39(8):1431-1438. PubMed ID: 31203399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
    Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
    Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of inhibition of a catabolic pathway of methotrexate metabolism in its efficacy for rheumatoid arthritis.
    Morgan SL; Baggott JE
    Med Hypotheses; 2019 Jan; 122():10-15. PubMed ID: 30593388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation specific environment activated methotrexate-loaded nanomedicine to treat rheumatoid arthritis by immune environment reconstruction.
    Tian J; Chen T; Huang B; Liu Y; Wang C; Cui Z; Xu H; Li Q; Zhang W; Liang Q
    Acta Biomater; 2023 Feb; 157():367-380. PubMed ID: 36513249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte/Macrophage Immune Responses.
    Yoon BR; Oh YJ; Kang SW; Lee EB; Lee WW
    Front Immunol; 2018; 9():53. PubMed ID: 29422900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients.
    Heinicke F; Zhong X; Flåm ST; Breidenbach J; Leithaug M; Mæhlen MT; Lillegraven S; Aga AB; Norli ES; Mjaavatten MD; Haavardsholm EA; Zucknick M; Rayner S; Lie BA
    Front Immunol; 2021; 12():663736. PubMed ID: 33897713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.
    Lundström SL; Hensvold AH; Rutishauser D; Klareskog L; Ytterberg AJ; Zubarev RA; Catrina AI
    Arthritis Res Ther; 2017 Aug; 19(1):182. PubMed ID: 28793911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased circulating CD14brightCD16+ intermediate monocytes are regulated by TNF-α and IL-6 axis in accordance with disease activity in patients with rheumatoid arthritis.
    Tsukamoto M; Suzuki K; Seta N; Takeuchi T
    Clin Exp Rheumatol; 2018; 36(4):540-544. PubMed ID: 29465348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting methotrexate resistance in rheumatoid arthritis patients.
    Yu MB; Firek A; Langridge WHR
    Inflammopharmacology; 2018 Jun; 26(3):699-708. PubMed ID: 29532212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile.
    Soler Palacios B; Estrada-Capetillo L; Izquierdo E; Criado G; Nieto C; Municio C; González-Alvaro I; Sánchez-Mateos P; Pablos JL; Corbí AL; Puig-Kröger A
    J Pathol; 2015 Feb; 235(3):515-26. PubMed ID: 25319955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.